Baxter To Distribute Ceprate During Cellpro Bankruptcy Until Isolex Approval

Baxter will distribute Cellpro's Ceprate stem cell concentration system worldwide pending approval of Nexell's Isolex stem cell collection system under a bankruptcy plan for CellPro.

More from Archive

More from Medtech Insight